Description

Description

Systemic Neuro-Metabolic & Cellular Bioenergetics Stack
1 Bac Water | 1 24mg Retatrutide | 2 70mg Glow Blend (GHK-Cu / BPC-157 / TB-500) | 1 1000mg NAD+ | 2 10mg Semax
The Systemic Neuro-Metabolic & Cellular Bioenergetics Stack synthesizes four complementary compounds engineered to address whole-organism vitality across metabolic, structural, mitochondrial, and cognitive axes. By integrating a multi-pathway incretin and glucagon receptor tri-agonist, a multi-peptide dermal and extracellular matrix renewal complex (Glow), a vital cellular coenzyme for ATP generation and sirtuin activation (NAD+), and a synthetic melanocortin-derived neurotrophic peptide (Semax), this stack provides a broad, multi-target model for investigating the crosstalk between cellular longevity, systemic body composition, and central nervous system resilience.
Mechanism Of Action
  • Tri-Receptor Incretin & Glucagon Co-Agonism: Retatrutide coordinates agonism across GLP-1, GIP, and glucagon (GCGR) receptors. This triple action enhances insulinotropic signaling, suppresses inappropriate glucagon secretion under hyperglycemic conditions, stimulates basal metabolic rate via glucagon-mediated hepatic energy expenditure, and promotes rapid mobilization of adipose tissue.
  • Extracellular Matrix Synthesis and Microvascular Renewal: The Glow blend integrates GHK-Cu, BPC-157, and TB-500 to drive collagen I and III production, downregulate tissue metalloproteinases, and stimulate microvascular endothelial growth. This promotes cellular migration, dermal fibroblast proliferation, and systemic structural repair.
  • Mitochondrial Respiration and Sirtuin Activation: Exogenous NAD+ (Nicotinamide Adenine Dinucleotide) replenishes intracellular redox pools critical for mitochondrial oxidative phosphorylation and electron transport chain efficiency. Elevated NAD+ pools serve as direct substrates for sirtuins (SIRT1–SIRT7) and poly(ADP-ribose) polymerases (PARPs), regulating oxidative stress responses and genomic integrity.
  • Neurotrophin Upregulation and Central Neuroprotection: Semax (an ACTH 4–10 analog stabilized with Pro-Gly-Pro) rapidly crosses the blood-brain barrier to stimulate the expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) within hippocampal and cortical circuits. It modulates dopaminergic and serotonergic turnover to sustain cognitive focus, reduce neuroinflammation, and preserve synaptic plasticity.
Potential Benefits
  • Comprehensive Neuro-Cognitive Enhancement: Combines the neurogenic and BDNF-stimulating actions of Semax with the energetic substrates of NAD+, fostering heightened cognitive clarity, processing speed, sustained attention, and resistance to neurodegenerative stressors.
  • Advanced Metabolic Reprogramming & Lipolysis: Retatrutide drives robust, dose-dependent adipocyte lipolysis and satiety regulation, optimizing whole-body substrate utilization without sacrificing lean functional tissue.
  • Cellular Bioenergetics and Mitochondrial Vitality: Direct NAD+ replenishment supports ATP availability across metabolically demanding tissues (cardiac, muscle, and cerebral), countering cellular senescence and fatigue at the bioenergetic level.
  • Systemic Dermal and Connective Rejuvenation: The Glow peptide complex targets dermal elasticity, skin matrix thickness, collagen cross-linking, and microvascular repair to promote tissue revitalization and structural resilience.
Research Studies
  • Targeted Incretin/Glucagon Tri-Agonism: Clinical Phase 2 and preclinical trials identify Retatrutide as a breakthrough multi-receptor agonist, demonstrating superior reductions in adiposity, improvements in hepatic steatosis markers, and sustained glycemic stabilization relative to dual- or single-agonist controls.
  • Intracellular Coenzyme Dynamics and Longevity Signatures: In vitro and in vivo studies highlight that re-establishing optimal NAD+/NADH ratios restores mitochondrial efficiency, activates sirtuin-mediated epigenetic maintenance, and mitigates oxidative damage in aging cells.
  • BDNF Induction and Synaptic Plasticity: Neurological literature confirms Semax’s ability to elevate BDNF and TrkB receptor gene transcription within hours of administration, providing sustained neuroprotective effects and enhanced memory consolidation in stress-exposed models.
  • GHK-Cu and Multi-Peptide Tissue Remodeling: Investigative assays confirm that copper peptide complexes combined with regenerative peptides induce fibroblast proliferation, stimulate glycosaminoglycan synthesis, and enhance local tissue perfusion.
Conclusion
The integration of Retatrutide, the Glow blend, NAD+, and Semax establishes a dynamic experimental platform targeting the core pillars of organismal performance: metabolic equilibrium, extracellular regeneration, bioenergetic availability, and cognitive optimization. By bridging somatic repair with central nervous system neurotrophy, this stack provides a comprehensive protocol for evaluating the convergence of metabolic health, cellular anti-aging mechanisms, and cognitive longevity.
Disclaimer
The information provided is intended solely for research and educational purposes. It is not meant as medical advice, nor should it be used for diagnosis, treatment, prevention, or cure of any disease or health condition. These are research chemicals and are not approved for human use by the FDA or any other regulatory body. Their safety and efficacy for human use have not been established. Users are advised to conduct thorough research and consult with qualified healthcare professionals before considering their use. All experimentation should be conducted in accordance with relevant laws, regulations, and ethical guidelines.